chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Spinal cord compression, Spinal fusion surgery, Spinal retrolisthesis, Urinary incontinence
Clinical narrative: Patient discharged after (4) day in patient admission.  Patient is a 61 y.o. female who presents today after a fall at home last night inside her home.  Patient was walking from the bathroom to the living room, when her lower extremity weakness caused her to fall onto her left side.  Patient was able to contact her son and get herself to the chair after being on the floor for about 10 minutes.  She states that she has been having progressive weakness in her arms and legs with numbness and tingling.  She has been having workup for the past few months in regards to this.  She has had an MRI of the brain which was unremarkable.  She had a MRI cervical spine which showed C4-5 spinal count stenosis and C3-C4 and C4-C5 foraminal stenosis.  She was also scheduled to get MRI lumbar spine, however, this was unable to be performed.  She was refer to ortho spine, and PM&R.  Patient states that she was told that if she has any worsening symptoms she did come to the emergency department.  She states that in the last few weeks she has had increasing bladder and bowel incontinence.  She feels like she has more weakness and numbness in her extremities as well.  She continues to have pain in her neck as well as her lower back.   Emergency department, patient is hemodynamically stable.  Labs show hemoglobin of 9.9, though she does have a history of chronic anemia.  X-ray of her left knee as well as tib/fib did not show any acute fracture.  Patient unable to ambulate well and therefore it was felt that she should be admitted for further observation and evaluation.  PLAN B/L Upper and lower extremity weakness/numbness Bladder and rectal incontinence Multiple falls: - MRI cervical spine from 09/14 shows moderate C4-5 spinal canal stenosis with effacement of ventral and dorsal CSF and compression of the cord.  Severe right C3-4 and left C4-5 foraminal stenosis.  Bilateral C3-4 and C4-5 facet effusions with edema.   - left knee xray negative for acute fracture - left tibia/fibula xray negative for acute fracture - increasing number of falls over past few weeks - neuro checks - MRI lumbar spine - consult orthospine - consult PT/OT   Asymptomatic COVID-19: - incidental findings - patient has a sore throat but otherwise without shortness of breath or cough - onset unknown - consider reaching out to Monoclonal antibody team in AM for treatment if patient is eligible.     Chronic anemia: - occasional bleeding from hemorrhoids - check iron studies - repeat hgb in AM   Hypothyroid: - check TSH (last check in 5/2021 was WNL) - continue levothyroxine   Essential hypertension: - continue atenolol and diltiazem   GERD: - continue PPI   RLL syndrome: - continue ropinirole   DVT prophylaxis: early and progressive mobilization Code Status:  Full code, per discussion with patient
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vertebral foraminal stenosis, Vertebral lateral recess stenosis, X-ray limb normal
Clinical narrative: Patient discharged after (4) day in patient admission.  Patient is a 61 y.o. female who presents today after a fall at home last night inside her home.  Patient was walking from the bathroom to the living room, when her lower extremity weakness caused her to fall onto her left side.  Patient was able to contact her son and get herself to the chair after being on the floor for about 10 minutes.  She states that she has been having progressive weakness in her arms and legs with numbness and tingling.  She has been having workup for the past few months in regards to this.  She has had an MRI of the brain which was unremarkable.  She had a MRI cervical spine which showed C4-5 spinal count stenosis and C3-C4 and C4-C5 foraminal stenosis.  She was also scheduled to get MRI lumbar spine, however, this was unable to be performed.  She was refer to ortho spine, and PM&R.  Patient states that she was told that if she has any worsening symptoms she did come to the emergency department.  She states that in the last few weeks she has had increasing bladder and bowel incontinence.  She feels like she has more weakness and numbness in her extremities as well.  She continues to have pain in her neck as well as her lower back.   Emergency department, patient is hemodynamically stable.  Labs show hemoglobin of 9.9, though she does have a history of chronic anemia.  X-ray of her left knee as well as tib/fib did not show any acute fracture.  Patient unable to ambulate well and therefore it was felt that she should be admitted for further observation and evaluation.  PLAN B/L Upper and lower extremity weakness/numbness Bladder and rectal incontinence Multiple falls: - MRI cervical spine from 09/14 shows moderate C4-5 spinal canal stenosis with effacement of ventral and dorsal CSF and compression of the cord.  Severe right C3-4 and left C4-5 foraminal stenosis.  Bilateral C3-4 and C4-5 facet effusions with edema.   - left knee xray negative for acute fracture - left tibia/fibula xray negative for acute fracture - increasing number of falls over past few weeks - neuro checks - MRI lumbar spine - consult orthospine - consult PT/OT   Asymptomatic COVID-19: - incidental findings - patient has a sore throat but otherwise without shortness of breath or cough - onset unknown - consider reaching out to Monoclonal antibody team in AM for treatment if patient is eligible.     Chronic anemia: - occasional bleeding from hemorrhoids - check iron studies - repeat hgb in AM   Hypothyroid: - check TSH (last check in 5/2021 was WNL) - continue levothyroxine   Essential hypertension: - continue atenolol and diltiazem   GERD: - continue PPI   RLL syndrome: - continue ropinirole   DVT prophylaxis: early and progressive mobilization Code Status:  Full code, per discussion with patient
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Dysgeusia, Headache, Nausea
Clinical narrative: Pain in my arms, legs, and back - lasted 1 day Headache - lasted 1 day Diarrhea - lasted 1 day Nausea - lasted 1 day Metallic taste - ongoing
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in my arms, legs, and back - lasted 1 day Headache - lasted 1 day Diarrhea - lasted 1 day Nausea - lasted 1 day Metallic taste - ongoing
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: vomiting hourly fever of 101.4+ Treated with Tylenol, Zofran
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Interchange of vaccine products, Tinnitus
Clinical narrative: Exaserbated the ringing in my head from the Pfizer vaccine that I received on April 14th.  I previously reported this event.  The Pfizer number is ER8727.   The ringing in my head is persistent and louder.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Chest X-ray normal, Echocardiogram normal, Electrocardiogram normal, Laboratory test normal
Clinical narrative: Strong heart beats and mostly upper body muscle twitching
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Strong heart beats and mostly upper body muscle twitching
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Aortic arteriosclerosis, Asthenia, Blood culture positive, C-reactive protein increased
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Faeces discoloured, Fatigue
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Gastrointestinal haemorrhage, Gram stain positive, Haemoglobin decreased, Hypopnoea
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Inflammation, Influenza A virus test, Influenza B virus test, Lung disorder
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Macrocytosis, Nasal congestion, Occult blood negative, Pneumonia
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, Respiratory syncytial virus test, Rouleaux formation, SARS-CoV-2 test positive
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Sepsis, Serum ferritin increased, Staphylococcus test positive, Systemic inflammatory response syndrome, Tachycardia
Clinical narrative: Patient discharged after (4) day inpatient admission.  PRESENTING PROBLEM: Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type Pneumonia due to COVID-19 virus COVID-19    HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for ESRD, on dialysis for last 6 years, hypertension, diabetes, history of GI bleeds in the past, history of atrial fibrillation not on anticoagulation due to GI bleed, chronic venous stasis presents to the hospital on 12/03 with complaints of generalized weakness, fatigue, cough, nasal congestion for about  1.5 weeks.   Sirs/sepsis POA due to COVID-19 infection.  Patient's fever and tachycardia resolved with supportive treatment   COVID-19 infection/pneumonia, without hypoxia and did not qualify for any therapeutics.  Supportive treatment with antitussives.  She did have elevated D-dimer, mild but had no signs of DVT.   Anemia, noted to have a hemoglobin of 8 at admit with hemoglobin of 12 in September 2021. She denies any history of hematochezia or black tarry stools but does have chronic formed black color stools due to iron supplement.  GI was consulted but they recommended outpatient EGD/colonoscopy.  Fecal occult blood was negative.  Hematology consultation was requested given macrocytosis and rouleaux formation.  FLC ratio was normal even though they were both elevated.  Ferritin level was also quite elevated along with CRP.  This certainly was heightened inflammatory state likely related to COVID infection.  Hematology felt that in-patient bone marrow biopsy would not be needed and recommended outpatient follow-up for evaluation of MDS.  Patient did receive EPO at dialysis.   She did have 1/2 positive blood culture for CNS, contaminant   Nephrology assisted with dialysis.  Given her COVID status, Care Management assisted with arrangement of alternative dialysis site until she is out of isolation.  She should be able to be done with isolation AFTER 12/9   Patient's blood pressures were in the low normal range, hence her Coreg dose was reduced to 1/4 the home dosage a new prescription was written.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer, Gait disturbance, Muscular weakness, Pain in extremity, Peripheral swelling
Clinical narrative: I was waiting my 15 minutes after receiving my vaccine. I had my feet up on the chair and when I got up and made my first step, I had a terrible pain in my leg. I limped to my car and sat in my car for an additional 10 minutes. While sitting there, my vision was blurred. It cleared up in about 15 minutes and I drove home. The rest of the day, I walked around the house with a limp and I had swelling in the back of my knee. I went to my GP and he gave me a D-Dimer test. They called a few hours later with the results that it was positive for a blood clot. There was an ultrasound performed on both legs to locate the blood clot. No one was able to locate the blood clot and I was not given any medication for it. I called the doctor, a couple of days later. and she had me come in and she performed another D-Dimer test and that one came back negative. About two months after seeing her, I was still experiencing weakness in my leg. There was a lot of swelling behind my left leg, but everything is fine now.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis, Ultrasound scan, Vision blurred
Clinical narrative: I was waiting my 15 minutes after receiving my vaccine. I had my feet up on the chair and when I got up and made my first step, I had a terrible pain in my leg. I limped to my car and sat in my car for an additional 10 minutes. While sitting there, my vision was blurred. It cleared up in about 15 minutes and I drove home. The rest of the day, I walked around the house with a limp and I had swelling in the back of my knee. I went to my GP and he gave me a D-Dimer test. They called a few hours later with the results that it was positive for a blood clot. There was an ultrasound performed on both legs to locate the blood clot. No one was able to locate the blood clot and I was not given any medication for it. I called the doctor, a couple of days later. and she had me come in and she performed another D-Dimer test and that one came back negative. About two months after seeing her, I was still experiencing weakness in my leg. There was a lot of swelling behind my left leg, but everything is fine now.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Bone pain, Contusion, Decreased appetite
Clinical narrative: 1) Metallic taste  within 30 minutes after shot; metallic taste lasted for about four hours.  This was followed by pain and burning feeling on tongue and burning and stinging feeling on lips, which continues to be a problem as of today?s date.  Tongue also feels swollen but does not visually appear swollen.  2) Feeling of hyperactivity, jitteriness and insomnia immediately after shot, which still persists.  3) Loss of appetite and weight loss immediately after shot, which persists.  Stomach pain developed about one week after second dose on November 26, 2021.  4)  Blurry vision  immediately after shot and remains intermittent.  5) Pain in bones and joints, including knees, elbows, shoulder, hips, feet, which developed about one week after shot and persist today.  Limitation in shoulder mobility developed immediately after second dose and has only improved slightly after two weeks.  6) Intermittent feeling of burning up but no fever.  7) Intermittent headaches, which developed about one week after shot, and persist today.  8) Unexplained bruising, which developed about one week after second dose on  November 26,  2021.  9) General feeling of being unwell within 30 minutes of first shot and persists today.  10) Intermittent diarrhea within one day of shot and symptom continues intermittently.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dysgeusia, Feeling hot, Feeling jittery, Glossodynia
Clinical narrative: 1) Metallic taste  within 30 minutes after shot; metallic taste lasted for about four hours.  This was followed by pain and burning feeling on tongue and burning and stinging feeling on lips, which continues to be a problem as of today?s date.  Tongue also feels swollen but does not visually appear swollen.  2) Feeling of hyperactivity, jitteriness and insomnia immediately after shot, which still persists.  3) Loss of appetite and weight loss immediately after shot, which persists.  Stomach pain developed about one week after second dose on November 26, 2021.  4)  Blurry vision  immediately after shot and remains intermittent.  5) Pain in bones and joints, including knees, elbows, shoulder, hips, feet, which developed about one week after shot and persist today.  Limitation in shoulder mobility developed immediately after second dose and has only improved slightly after two weeks.  6) Intermittent feeling of burning up but no fever.  7) Intermittent headaches, which developed about one week after shot, and persist today.  8) Unexplained bruising, which developed about one week after second dose on  November 26,  2021.  9) General feeling of being unwell within 30 minutes of first shot and persists today.  10) Intermittent diarrhea within one day of shot and symptom continues intermittently.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Joint range of motion decreased, Lip pain, Malaise
Clinical narrative: 1) Metallic taste  within 30 minutes after shot; metallic taste lasted for about four hours.  This was followed by pain and burning feeling on tongue and burning and stinging feeling on lips, which continues to be a problem as of today?s date.  Tongue also feels swollen but does not visually appear swollen.  2) Feeling of hyperactivity, jitteriness and insomnia immediately after shot, which still persists.  3) Loss of appetite and weight loss immediately after shot, which persists.  Stomach pain developed about one week after second dose on November 26, 2021.  4)  Blurry vision  immediately after shot and remains intermittent.  5) Pain in bones and joints, including knees, elbows, shoulder, hips, feet, which developed about one week after shot and persist today.  Limitation in shoulder mobility developed immediately after second dose and has only improved slightly after two weeks.  6) Intermittent feeling of burning up but no fever.  7) Intermittent headaches, which developed about one week after shot, and persist today.  8) Unexplained bruising, which developed about one week after second dose on  November 26,  2021.  9) General feeling of being unwell within 30 minutes of first shot and persists today.  10) Intermittent diarrhea within one day of shot and symptom continues intermittently.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort, Pain in extremity, Psychomotor hyperactivity, Swollen tongue, Tongue discomfort
Clinical narrative: 1) Metallic taste  within 30 minutes after shot; metallic taste lasted for about four hours.  This was followed by pain and burning feeling on tongue and burning and stinging feeling on lips, which continues to be a problem as of today?s date.  Tongue also feels swollen but does not visually appear swollen.  2) Feeling of hyperactivity, jitteriness and insomnia immediately after shot, which still persists.  3) Loss of appetite and weight loss immediately after shot, which persists.  Stomach pain developed about one week after second dose on November 26, 2021.  4)  Blurry vision  immediately after shot and remains intermittent.  5) Pain in bones and joints, including knees, elbows, shoulder, hips, feet, which developed about one week after shot and persist today.  Limitation in shoulder mobility developed immediately after second dose and has only improved slightly after two weeks.  6) Intermittent feeling of burning up but no fever.  7) Intermittent headaches, which developed about one week after shot, and persist today.  8) Unexplained bruising, which developed about one week after second dose on  November 26,  2021.  9) General feeling of being unwell within 30 minutes of first shot and persists today.  10) Intermittent diarrhea within one day of shot and symptom continues intermittently.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Weight decreased
Clinical narrative: 1) Metallic taste  within 30 minutes after shot; metallic taste lasted for about four hours.  This was followed by pain and burning feeling on tongue and burning and stinging feeling on lips, which continues to be a problem as of today?s date.  Tongue also feels swollen but does not visually appear swollen.  2) Feeling of hyperactivity, jitteriness and insomnia immediately after shot, which still persists.  3) Loss of appetite and weight loss immediately after shot, which persists.  Stomach pain developed about one week after second dose on November 26, 2021.  4)  Blurry vision  immediately after shot and remains intermittent.  5) Pain in bones and joints, including knees, elbows, shoulder, hips, feet, which developed about one week after shot and persist today.  Limitation in shoulder mobility developed immediately after second dose and has only improved slightly after two weeks.  6) Intermittent feeling of burning up but no fever.  7) Intermittent headaches, which developed about one week after shot, and persist today.  8) Unexplained bruising, which developed about one week after second dose on  November 26,  2021.  9) General feeling of being unwell within 30 minutes of first shot and persists today.  10) Intermittent diarrhea within one day of shot and symptom continues intermittently.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.5 ml Im Moderna Booster vaccine
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: PATIENT CAME AND ALREADY HAD AN APPOINTMENT MADE, VACCINATOR AND VACCINATOR SUPPORT DID NOT COMMUNICATE WELL ENOUGH AND DID NOT REALIZE PATIENT WAS STILL A MINOR AND THE VACCINE HAD ALREADY BEEN GIVEN. PATIENT WAS FINE AND FELT NORMAL.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Angiogram pulmonary abnormal, Anion gap, Aspartate aminotransferase normal, Blood albumin decreased
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase increased, Blood bilirubin normal, Blood calcium decreased, Blood chloride increased, Blood creatinine normal
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea increased, COVID-19
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Cough, Dyspnoea, Fatigue
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate normal, Haematocrit decreased, Haemoglobin decreased, Hypoxia, Lung infiltration
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume decreased, Nausea, Neutrophil count, Pain, Platelet count decreased
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Protein total decreased, Pulmonary mass, Red blood cell count normal, SARS-CoV-2 test positive
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast normal, Splenomegaly, White blood cell count normal
Clinical narrative: Patient discharged after (2) day inpatient admission. Patient is a 60-year-old male with history of recently identified pulmonary nodules and splenomegaly (undergoing further work-up) who presented with cough and shortness of breath.  He had received his COVID booster on 11/30, after which he developed body aches, nausea and fatigue.  He tested positive for COVID on 12/6, and received Regeneron therapy immediately afterwards.  Despite this, he had ongoing/worsening cough and shortness of breath, so came to the ED on 12/7.  In the ED, he was hypoxemic down to 88-90% on room air, and was placed on 2 L oxygen.  He was given Albuterol inhaler and Decadron, and was admitted to the hospitalist service for further work-up and management.   Upon admission, he was continued on oral Decadron.  He initially required 2 L oxygen, but was able to be weaned back to room air.  He underwent CTA chest, which showed bilateral infiltrates consistent with bronchopneumonia and perilymphatic nodules, as well as persistent splenomegaly.  There was no evidence of PE.  He had improvement in his shortness of breath and hypoxia over the next 24 hours, and felt stable for discharge on 12/09.   He was discharged home on 12/09/2021.  He will be discharged on 6 mg of Decadron for 5 more days.  He should follow-up with his PCP in 1 week.  He has already rescheduled his bronchoscopy, as planned by Pulmonology, on 12/21/2021.   CONSULTS / RECOMMENDATION: None   INPATIENT PROCEDURES: None
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives that started a week after the vaccine that have been present for a week
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenitis
Clinical narrative: Patient had an inflamed and painful lymph node on the left side on the neck the day after the vaccine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Patient left voicemail stating she had a small rash on her arm and soreness after receiving the vaccine.